ORGO CIK: 1661181

Organogenesis Holdings Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY24
millions USD
FY21:
353
FY22:
346
FY23:
327
FY24:
366
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
72.2
FY22:
22.3
FY23:
−94.0
FY24:
−117
FY25:
44.7
(positive)
Change from FY21 to FY23
millions USD
FY21:
88.9
FY22:
40.3
FY23:
36.0
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
63.1
FY22:
20.3
FY23:
10.4
FY24:
−2.81
FY25:
47.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
94.2
FY22:
15.5
FY23:
4.95
FY24:
0.86
FY25:
37.0

All amounts in millions USD Data sources:SEC EDGARTwelve Data